Bibliography
- Institute of Medicine of the National Academies. Rare Diseases and Orphan Products: Accelerating Research and Development. Available from: http://www.iom.edu/∼/media/Files/Report%20Files/2010/Rare-Diseases-and-Orphan-Products-Accelerating-Research-and-Development/Rare%20Disease%20Research%202010%20Report%20Brief.pdf
- 21 U.S.C. §360bb
- Food and Drug Administration. For Industry: Designating an Orphan Product: Drugs and Biologics. Available from: http://www.fda.gov/ForIndustry/DevelopingProductsforRareDiseasesConditions/HowtoapplyforOrphanProductDesignation/default.htm [Accessed on 24 September 2012]
- Targan SR, Hanauer SB, van Deventer SJH, A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med 1997;337(15):1029-35
- Centocor, Inc. Remicade (infliximab) prescribing information. Malvern, PA: 1998
- Accurso FJ, Rowe SM, Clancy JP, Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 2010;363(21):1991-2003
- Vertex Pharmaceuticals, Inc. Kalydeco (ivacaftor) prescribing information. Cambridge, MA: 2012
- Food and Drug Administration. FDA News Release: FDA approves Kalydeco to treat rare form of cystic fibrosis. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm289633.htm [Accessed on 24 September 2012]
- Fraser CD, Jaquiss RDB, Rosenthal DN, Prospective trial of a pediatric ventricular assist device. N Engl J Med 2012;367(6):532-41
- Food and Drug Administration. FDA News Release: FDA approves mechanical cardiac assist device for children with heart failure. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm283956.htm [Accessed on 24 September 2012]
- Food and Drug Administration. Medical Devices: Listing of CDRH Humanitarian Device Exemptions. Available from: http://www.fda.gov/medicaldevices/productsandmedicalprocedures/deviceapprovalsandclearances/hdeapprovals/ucm161827.htm [Accessed on 24 September 2012]